Aspirin's Main Side Effects
Aspirin, an NSAID, inhibits COX-1 and COX-2 enzymes, blocking prostaglandin production to reduce pain and inflammation. Its key risks include gastrointestinal (GI) issues from COX-1 inhibition, which protects the stomach lining. Common effects: stomach ulcers, bleeding (2-4 times higher risk than non-users), heartburn.[1][2] It also raises bleeding risk overall by impairing platelet function, lasting days. Rare but serious: Reye's syndrome in children with viral infections, allergic reactions (hives, asthma worsening in 10-20% of asthmatics).[3]
How Newer NSAIDs Reduce GI Risks
Drugs like ibuprofen (1970s) and naproxen share aspirin's COX inhibition but are dosed lower for pain relief, cutting chronic GI bleed risk versus high-dose aspirin (e.g., daily 325mg).[4] Selective COX-2 inhibitors (coxibs) like celecoxib (Celebrex, approved 1998) spare COX-1, slashing ulcers and bleeds by 50-70% in trials.[1][5] Still, all NSAIDs carry some GI risk, higher with age or steroids.
Cardiovascular Trade-Offs in Newer Drugs
Aspirin protects the heart at low doses (81mg) by thinning blood, lowering clot risk—unlike most NSAIDs.[6] Coxibs like rofecoxib (Vioxx, withdrawn 2004) doubled heart attack/stroke risk after 18 months, leading to its pull.[7] Celecoxib has milder CV warnings but avoids aspirin's bleed benefit. Ibuprofen/naproxen show modest CV hikes at high doses, prompting FDA black-box warnings on all NSAIDs for heart risks.[2]
Other Differences: Kidneys, Liver, and Allergies
All NSAIDs stress kidneys (acute injury in 1-5% dehydrated users), but aspirin's effect is dose-dependent and reversible.[4] Liver issues are rare across classes; coxibs may edge out. Aspirin uniquely triggers NSAID-exacerbated respiratory disease (10% asthmatics), less common with coxibs.[3] Newer biologics like adalimumab (Humira) for inflammation bypass COX entirely, avoiding GI/CV issues but risking infections (TB reactivation).[8]
When Aspirin Stands Out Versus Modern Options
| Aspect | Aspirin | Traditional NSAIDs (ibuprofen, naproxen) | COX-2 Selectives (celecoxib) | Biologics (e.g., for rheumatoid arthritis) |
|--------|---------|------------------------------------------|------------------------------|-------------------------------------------|
| GI Bleeds | High | Medium | Low | None |
| CV Protection | Yes (low-dose) | Neutral/negative | Negative | Neutral |
| Bleeding Risk | High (platelets) | Low | Low | Low (infections instead) |
| Cost (generic monthly) | <$5 | <$10 | $20-50 | $2,000+ |
| Best For | Heart prevention, cheap pain | Everyday aches | Arthritis with GI history | Severe autoimmune inflammation |
Patients with ulcer history prefer coxibs; heart patients stick to low-dose aspirin.[1][5] Always check interactions—e.g., aspirin counters ibuprofen's pain relief.
Sources:
[1] FDA NSAID Label Warnings
[2] NEJM: GI Risks of NSAIDs
[3] AAAAI Aspirin Sensitivity
[4] Mayo Clinic NSAID Comparison
[5] Celecoxib CLASS Trial
[6] USPSTF Aspirin Recommendations
[7] NEJM Vioxx Withdrawal
[8] FDA Humira Label